T/GDACM 0115-2022 Gastric Cancer Postoperative Acupuncture Therapy Guideline

Scope

Main technical content: Gastric cancer is the third most common malignant tumor in terms of incidence and mortality worldwide. More than half of the cases occur in East Asia, and it is a highly prevalent tumor in China. Surgical resection is currently one of the treatment options with the potential to cure gastric cancer. However, some patients still need to receive adjuvant chemotherapy after surgery to reduce the risk of postoperative recurrence and metastasis. However, surgery and chemotherapy also bring many negative effects to patients, such as reducing their quality of life, interrupting chemotherapy plans, thereby increasing the risk of tumor recurrence and metastasis and shortening their survival time, even endangering their lives. A large number of studies have shown that acupuncture can promote postoperative recovery from gastric cancer, prevent and treat chemotherapy-related adverse reactions, and alleviate tumor-related symptoms. Traditional Chinese acupuncture has accumulated a large amount of clinical experience in the treatment of gastric cancer. To further standardize acupuncture treatment after gastric cancer surgery and during postoperative adjuvant chemotherapy, the guideline development working group, in accordance with the standard methods and steps of evidence-based clinical practice guidelines, combined with clinical needs and the characteristics of China's actual situation, developed the "Acupuncture Treatment Guidelines for Gastric Cancer after Surgery", which is in line with clinical practice, easy to implement, and has the characteristics of traditional Chinese acupuncture diagnosis and treatment. This document specifies the content of acupuncture treatment after gastric cancer surgery (including the postoperative recovery period and the postoperative adjuvant chemotherapy period) and is applicable to professionals in medical institutions and scientific research institutes at all levels across the country for scientific research and clinic

Development Information

Related Standards